Amlexanox
Chú thích

↑  “Amlexanox (Aphthasol®)”. Bản gốc lưu trữ ngày 20 tháng 11 năm 2013. Truy cập ngày 20 tháng 11 năm 2013.
↑  Gonsalves WC, Chi AC, Neville BW (February 2007). "Common oral lesions: Part I. Superficial mucosal lesions". Am Fam Physician. 75 (4): 501–7. PMID 17323710.
1 2  "Amlexanox". MedlinePlus. Hoa Kỳ National Library of Medicine. February 2009. Truy cập 12 February 2013.
1 2  Plewa MC (March 2012). "Pediatric Aphthous Ulcers Treatment & Management". Medscape Reference. Medscape. Truy cập 14 February 2013.
↑  "Amlexanox". PubChem. Hoa Kỳ National Library of Medicine. Truy cập 12 February 2013.
↑  Bailey J, McCarthy C, Smith RF (October 2011). "Clinical inquiry. What is the most effective way to treat recurrent canker sores?". J Fam Pract. 60 (10): 621–32. PMID 21977491.
↑  Yousefi M, Ferringer T, Lee S, Bang D (July 2012). "Dermatologic Aspects of Behcet Disease Treatment & Management". Medscape Reference. Medscape. Truy cập 14 February 2013.
1 2 3 4 5 6  Bell J (2005). "Amlexanox for the treatment of recurrent aphthous ulcers". Clin Drug Investig. 25 (9): 555–66. doi:10.2165/00044011-200525090-00001. PMID 17532700.
↑  "Amlexanox". MeSH. Hoa Kỳ National Library of Medicine. 2009. Truy cập 12 February 2013.
↑  Elad S, Epstein JB, von Bültzingslöwen I, Drucker S, Tzach R, Yarom N (March 2011). "Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents". Expert Opin Emerg Drugs. 16 (1): 183–202. doi:10.1517/14728214.2011.528390. PMID 21244328.
1 2  Reilly SM, Chiang SH, Decker SJ, Chang L, Uhm M, Larsen MJ, Rubin JR, Mowers J, White NM, Hochberg I, Downes M, Yu RT, Liddle C, Evans RM, Oh D, Li P, Olefsky JM, Saltiel AR (February 2013). "An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice". Nat. Med. 19 (3): 313–21. doi:10.1038/nm.3082. PMC 3594079. PMID 23396211.
↑  Oral, E. A., Reilly, S. M., Gomez, A. V., Meral, R., Butz, L., Ajluni, N.,... & Rus, D. (2017). Inhibition of IKKɛ and TBK1 improves glucose control in a subset of patients with type 2 diabetes. Cell Metabolism, 26(1), 157-170. doi:10.1016/j.cmet.2017.06.006
↑  US patent 5362737[liên kết hỏng], Kakubhai R. Vora, Atul Khandwala, Charles G. Smith, "Methods of treating aphthous ulcers and other mucocutaneous disorders with amlexanox",  assigned to Chemex Pharmaceuticals, Inc.
↑  Kuteyi T, Okwundu CI (2012). Kuteyi, Teslim (ed.). "Topical treatments for HIV-related oral ulcers". Cochrane Database Syst Rev. 1: CD007975. doi:10.1002/14651858.CD007975.pub2. PMID 22258979.
↑  Chiang SH, Bazuine M, Lumeng CN, Geletka LM, Mowers J, White NM, Ma JT, Zhou J, Qi N, Westcott D, Delproposto JB, Blackwell TS, Yull FE, Saltiel AR (September 2009). "The protein kinase IKKepsilon regulates energy balance in obese mice". Cell. 138 (5): 961–75. doi:10.1016/j.cell.2009.06.046. PMC 2756060. PMID 19737522.
↑  Nohara, A.; Ishiguro, T.; Ukawa, K.; Sugihara, H.; Maki, Y.; Sanno, Y. (1985). “Studies on Antianaphylactic Agents. 7. Synthesis of Antiallergic 5-Oxo-5H-\1]benzopyrano\2,3-b]pyridines”. Journal of Medicinal Chemistry. 28 (5): 559–68. doi:10.1021/jm50001a005. PMID 3989816.
Tổng hợp amlexanox: